The cardiac rhythm management industry looks like it needs of a jolt of its own, badly.A look at the earnings releases of two of the big three players in the CRM Market, Boston Scientific (NYSE:BSX) and St. Jude Medical (NYSE:STJ), reveals that the slump in the cardiac rhythm management business is more persistent than some [...]

Shares of Boston Scientific Corp. (NYSE:BSX) traded at unusually high volumes for two straight weeks during the recent roller coast on Wall Street, coming in at more than 120 million trades during the week ending July 29 and topping 140 million the week ending August 5.Last week shaped up to top [...]

Boston Scientific Corp. (NYSE:BSX) plans to spend $37 million on overseas research and development, this time at its R&D facility in Clonmel, Ireland.The Natick, Mass.-based company hopes to jump-start development of a next generation cardiac rhythm management system.The funding is partially supported by a grant from IDA Ireland, a quasi-public investment promotion agency, which also [...]

With all the turmoil in the US healthcare market, a port in the storm is not easy to find. A port that can accommodate an outsized tanker ship like Medtronic is even harder to locate. With two back-to-back acquisitions last month of Peak Surgical and Salient Surgical, the S.S. Medtronic took refuge in Surgery Harbor, committing nearly $600 million (net of previous ownership stakes) in a single day to nestle in with the hulking barges of Covidien and J&J.

In the stockapocalypse that was Manic Monday, medical technology and pharma stocks got a mere slap on the wrist compared with banking stocks that received a more humiliating pants-down whipping.It appears that pharma stocks fared better than medical device and biotech stocks. GlaxoSmithKline (NYSE:GSK) was down a mere 28 cents to close at $39.44 on [...]

The shakeup at Boston Scientific (NYSE:BSX) last week proved that while the sheriff may be headed for the sunset, he’s not ready to hang up his spurs just yet.With little more than a month past his two year anniversary of taking the helm at BSX, J. Raymond Elliott continues to re-shape the Natick, [...]

A rebounding Boston Scientific Corp. (NYSE:BSX) said it plans to eliminate up to 1,400 jobs as part of a restructuring program aimed at saving between $225 million to $275 million annually by 2013.The job cuts are “designed to strengthen operational effectiveness and efficiencies, increase competitiveness and support new investments, thereby increasing shareholder value,” according to [...]

Boston Scientific Corp. (NYSE:BSX) sank $150 million into a five-year plan to expand Chinese commercial operations, including establishing a wholly owned manufacturing site and developing training centers for Chinese health care providers.The Natick, Mass.-based med-tech giant also plans to increase its Chinese workforce six-fold from 200 to more than 1,200 while investing further in R&D [...]

Boston Scientific Corp. (NYSE:BSX) warned that 167 jobs may be cut from its Miami, Fla., facility between Sept. 20 and Oct. 7 this year, according to a filing with the Worker Adjustment & Retraining Notification department of the Florida Agency for Workforce Innovation on Friday.The Natick, Mass.-based medical device giant, which ranked [...]

Boston Scientific Corp. (NYSE:BSX) plans to hire 250 new employees for its manufacturing operation in Latin America, according to a report from Costa Rica.The Natick, Mass.-based medical device maker is expanding its engineering, production, quality control and process development roles in Heredia, just outside the capital city of San Jos . BSX also [...]